{
  "pmid": "14522567",
  "uid": "14522567",
  "title": "Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.",
  "abstract": "AIMS: RESOLVD study patients were randomized to candesartan (C), enalapril (E), or C+E. Patients were later randomized to metoprolol CR (M) or placebo. Examine impact of C or E (C/E), C+E, C+M/E+M, C+E+M on ventricular remodelling in heart failure (HF) over 43 weeks. METHODS AND RESULTS: Four hundred and twenty-six of 768 patients receiving C, E, or C+E were randomized to either M or placebo. Patients were New York Heart Association class II-IV, ejection fraction (EF) <0.40 and 6-min walk distance <500 m. Ejection fraction (EF), cardiac volumes, blood pressures, heart rates, and neurohormones were measured. End diastolic volumes changed +29.4+/-6.4 ml for C/E, +16.6+/-10.4 ml for C+E, +19.7+/-6.5 ml for C+M/E+M, and -6.4+/-7.5 ml for C+E+M (P< or =0.01). End systolic volumes changed +22.9+/-5.8 ml for C/E, +11.9+/-9.1 ml for C+E, +6.0+/-5.7 ml for C+E/E+M, and -16.5+/-7.0 ml for C+E+M (P< or =0.001). Ejection fraction changed +0.01+/-0.01 for C/E, +0.01+/-0.01 for C+E, +0.03+/-0.01 for C+M/E+M, and +0.05+/-0.01 for C+E+M (P< or =0.0001). No significant differences for blood pressure or neurohormones; heart rate for C+M/E+M and C+E+M decreased (P< or =0.01) vs C/E or C+E. CONCLUSION: C+E+M had a modest but beneficial effect on cardiac function compared to the other groups. Combination of C+E+M has potential for providing HF patients with further benefit.",
  "authors": [
    {
      "last_name": "McKelvie",
      "fore_name": "Robert S",
      "initials": "RS",
      "name": "Robert S McKelvie",
      "affiliations": [
        "Hamilton Health Sciences, General Division, Ontario, Hamilton, Canada. mckelrob@hhsc.ca"
      ]
    },
    {
      "last_name": "Rouleau",
      "fore_name": "Jean-Lucien",
      "initials": "JL",
      "name": "Jean-Lucien Rouleau",
      "affiliations": []
    },
    {
      "last_name": "White",
      "fore_name": "Michel",
      "initials": "M",
      "name": "Michel White",
      "affiliations": []
    },
    {
      "last_name": "Afzal",
      "fore_name": "Rizwan",
      "initials": "R",
      "name": "Rizwan Afzal",
      "affiliations": []
    },
    {
      "last_name": "Young",
      "fore_name": "James B",
      "initials": "JB",
      "name": "James B Young",
      "affiliations": []
    },
    {
      "last_name": "Maggioni",
      "fore_name": "Aldo P",
      "initials": "AP",
      "name": "Aldo P Maggioni",
      "affiliations": []
    },
    {
      "last_name": "Held",
      "fore_name": "Peter",
      "initials": "P",
      "name": "Peter Held",
      "affiliations": []
    },
    {
      "last_name": "Yusuf",
      "fore_name": "Salim",
      "initials": "S",
      "name": "Salim Yusuf",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "European heart journal",
    "iso_abbreviation": "Eur Heart J",
    "issn": "0195-668X",
    "issn_type": "Print",
    "volume": "24",
    "issue": "19",
    "pub_year": "2003",
    "pub_month": "Oct"
  },
  "start_page": "1727",
  "end_page": "1734",
  "pages": "1727-34",
  "language": "eng",
  "publication_types": [
    "Clinical Trial",
    "Comparative Study",
    "Journal Article",
    "Multicenter Study",
    "Randomized Controlled Trial",
    "Research Support, Non-U.S. Gov't"
  ],
  "keywords": [
    "Angiotensin Receptor Antagonists",
    "Angiotensin-Converting Enzyme Inhibitors",
    "Antihypertensive Agents",
    "Benzimidazoles",
    "Biphenyl Compounds",
    "Blood Pressure",
    "Cardiac Volume",
    "Double-Blind Method",
    "Drug Therapy, Combination",
    "Enalapril",
    "Female",
    "Heart Failure",
    "Heart Rate",
    "Humans",
    "Male",
    "Metoprolol",
    "Middle Aged",
    "Stroke Volume",
    "Survival Analysis",
    "Tetrazoles",
    "Treatment Outcome",
    "Ventricular Remodeling"
  ],
  "article_ids": {
    "pubmed": "14522567",
    "doi": "10.1016/s0195-668x(03)00477-9",
    "pii": "S0195668X03004779"
  },
  "doi": "10.1016/s0195-668x(03)00477-9",
  "dates": {
    "completed": "2003-12-10",
    "revised": "2021-12-03"
  },
  "chemicals": [
    "Angiotensin Receptor Antagonists",
    "Angiotensin-Converting Enzyme Inhibitors",
    "Antihypertensive Agents",
    "Benzimidazoles",
    "Biphenyl Compounds",
    "Tetrazoles",
    "Enalapril",
    "Metoprolol",
    "candesartan"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:11:41.088605",
    "pmid": "14522567"
  }
}